ALFA Finder
21:17 IST
BSE
Results Update
Aarti Drugs Results Update
Aarti Drugs reports Q2 FY27 revenue of ₹828.8 Crore and PAT of ₹82.8 Crore, up 83% YoY. Results reflect record quarterly EBITDA and margin expansion.
Aarti Drugs Ltd
- Share price
- ₹489.95
- Market cap
- ₹4,472 Cr
- Revenue (annual)
- ₹2,565 Cr
- Net profit (annual)
- ₹194.9 Cr
- P/E (TTM)
- 19.5×Sector 43.8×
- Promoter holding
- 54.07%-0.36% QoQ
- FII holding
- 2.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 7Other Announcement 6Board Meeting Date 4Results Update 3Legal & Regulatory 3Financial Results 3Management Change 2Annual General Meeting 2Share Pledge 1Promoter Selling 1Employee Stock Options 1Business Update 1Board Meeting Outcome 1Annual Report 1Adverse Business Impact 1
Time
3 announcements with these filters
17:12 IST
NSE
Results Update
Aarti Drugs Results Update
Aarti Drugs reported Q1 FY27 consolidated revenue of ₹703.6 crore and EBITDA of ₹96.9 crore, reflecting 19% and 30% YoY growth respectively.
14:33 IST
NSE
Results Update
Aarti Drugs Results Update
Aarti Drugs reported FY26 revenue of ₹2,567.7 Crore, reflecting 7% year-on-year growth. Net profit reached ₹194.9 Crore, driven by strong sequential recovery and operational scale-up.
- Value
- ₹2,568 Cr